Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer

Details for Australian Patent Application No. 2005214017 (hide)

Owner Ohno, T.

Inventors Ohno, Tsuneya

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005214017

PCT Pub. Number WO2005/079271

Priority 10/778,717 12.02.04 US

Filing date 11 February 2005

Wipo publication date 1 September 2005

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

Event Publications

28 September 2006 PCT application entered the National Phase

  PCT publication WO2005/079271 Priority application(s): WO2005/079271

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214018-Compositions of non-steroidal antiinflammatory drugs and decongestants or anti-histamines

2005214013-Methods for protein production